Brainstorm Cell Therapeutics Inc. Stock Forecast
Volatile ride for Brainstorm Cell Therapeutics Inc. stock price on Wednesday moving between $0.510 and $0.686
(Updated on Mar 27, 2024)
The Brainstorm Cell Therapeutics Inc. stock price fell by -9.06% on the last day (Wednesday, 27th Mar 2024) from $0.660 to $0.600. During the last trading day the stock fluctuated 34.57% from a day low at $0.510 to a day high of $0.686. The price has risen in 6 of the last 10 days and is up by 81.55% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -221 thousand shares and in total, 1 million shares were bought and sold for approximately $760.63 thousand.
The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $0.663 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 34.26% during the next 3 months and, with a 90% probability hold a price between $0.455 and $0.89 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
BCLI Signals & Forecast
The Brainstorm Cell Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.547 and $0.389. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, March 26, 2024, and so far it has fallen -9.06%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Support, Risk & Stop-loss for Brainstorm Cell Therapeutics Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $0.570 and $0.507. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Brainstorm Cell Therapeutics Inc. finds support just below today's level at $0.570. If this is broken, then the next support from accumulated volume will be at $0.507 and $0.480.
This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.176 between high and low, or 34.57%. For the last week the stock has had daily average volatility of 30.93%.
Our recommended stop-loss: $0.567 (-5.52%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 1 day ago.)
Trading Expectations (BCLI) For The Upcoming Trading Day Of Thursday 28th
For the upcoming trading day on Thursday, 28th we expect Brainstorm Cell Therapeutics Inc. to open at $0.599, and during the day (based on 14 day Average True Range), to move between $0.519 and $0.681, which gives a possible trading interval of +/-$0.0812 (+/-13.52%) up or down from last closing price. If Brainstorm Cell Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 27.05% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.570 (5.03%) than the resistance at $0.655 (9.13%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Brainstorm Cell Therapeutics Inc. stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Brainstorm Cell Therapeutics Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.
Current score: 2.591 Buy Candidate Upgraded
Predicted Opening Price for Brainstorm Cell Therapeutics Inc. of Thursday, March 28, 2024
Fair opening price March 28, 2024 | Current price |
---|---|
$0.599 ( 0.228%) | $0.600 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for BCLI
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 0.775 | 29.15 % | |
R2 | 0.708 | 17.93 % | ||
R1 | 0.666 | 10.99 % | ||
Current price: | 0.600 | |||
Support | S1 | 0.531 | -11.45 % | |
S2 | 0.490 | -18.38 % | ||
S3 | 0.423 | -29.60 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 0 | . | |
R2 | 0.660 | 9.96 % | ||
R1 | 0.655 | 9.13 % | ||
Current price | 0.600 | |||
Support | S1 | 0.570 | -5.03% | |
S2 | 0.507 | -15.53% | ||
S3 | 0.480 | -20.03% |
FAQ
Click here for our free guide on how to buy Brainstorm Cell Therapeutics Inc. Stock.